Composition of inhibiting pathological angiogenesis
AssigneeTty Biopharm Company Limited
InventorsMin-Liang Kuo, Yu-Ling Wu
Life of this patent
Estimating the term…
Abstract
The present invention provides a pharmaceutical composition for inhibiting pathologic angiogenesis and/or cell proliferative disorder. The pharmaceutical composition of the present invention comprises an effective amount of LECT2 protein or analogue thereof, and a pharmaceutically acceptable carrier.
Claims43
A composition for inhibiting pathologic angiogenesis in an individual, comprising an effective amount of LECT2 protein or analogue thereof, and a pharmaceutically acceptable carrier.
A composition for treatment and/or inhibition of cell proliferative disorder in an individual, comprising an effective amount of LECT2 protein or analogue thereof, and a pharmaceutically acceptable carrier.
Use of LECT2 protein or analogue thereof for the preparation of a pharmaceutical composition for inhibiting pathologic angiogenesis.
Use of LECT2 protein or analogue thereof for the preparation of a pharmaceutical composition for the treatment and/or inhibition of cell proliferative disorder.
A method for inhibiting pathologic angiogenesis, comprising administering an effective amount of LECT2 protein or analogue thereof, and a pharmaceutically acceptable carrier to an individual.
Dependencies are inferred from the claim text.